NCT05743985View on ClinicalTrials.gov

Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

April 30, 2024

Conditions
Health, SubjectiveInflammatory ResponseAdverse EffectSide Effect
Interventions
OTHER

Cannabigerol

Hemp-derived full spectrum cannabigerol oil carried in an organic coconut (MCT) oil within hydroxypropyl methylcellulose capsules.

Trial Locations (6)

75126

Modern Medicine, Forney

76016

Institute for Hormonal Balance, Arlington

76092

Melville Medicine, Southlake

76201

NP Care Clinic, Denton

78539

Infectious Disease Specialists, Edinburg

00735

Java Med, Ceiba

All Listed Sponsors
lead

Formula30A LLC

INDUSTRY